¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) 2021 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2021)-4¿ù 1ÀÏ : 2021-04-01

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) 2021 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2021)-4¿ù 1ÀÏ : 2021-04-01
±³À°ÀÏÀÚ : 2021-04-01
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2021)-4¿ù 1ÀÏ      
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : À±ÁöÇý
¿¬¶ôó : 02-566-6031  
À̸ÞÀÏ : hematology@kams.or.kr      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú      
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 150,000¿ø      
ºñ°í ´ëÇÑÇ÷¾×ÇÐȸ ȸ¿ø £Ü50,000, Æç·Î¿ì/°£È£»ç/¿¬±¸¿ø £Ü30,000Çлý/Àü°øÀÇ £Ü20,000, ºñȸ¿ø £Ü150,000      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 01ÀÏ Room 1 09:00~09:30 Contemporary Treatment of Pediatric Ph+ ALL  Kirk Schultz(University of British Columbia Canada) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 1 09:30~10:00 Current Treatment Approaches to Newly Diagnosed Adult ALL  Daniel Joseph DeAngelo(Dana Farber Cancer Institute USA) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 1 10:00~10:30 Results of High Risk and Novel Subtypes of Pediatric ALL in Japan  Katsuyoshi Koh(Saitama Children's Medical Center Japan) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 1 10:30~11:15 Clonal Hematopoiesis and the Origin of Hematologic Malignancies  Benjamin Ebert(Dana-Farber Cancer Institute USA) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 1 11:30~12:10 New Treatment Option for FLT3 mutant AML  Alexander Edward Perl(University of Pennsylvania USA) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 1 12:55~13:25 From Korean Perspective  µµ¿µ·Ï(°è¸íÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 1 13:25~13:55 From Chinese Perspective  Qian Jiang(Peking University China) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 1 13:55~14:25 From Japanese Perspective  Shinya Kimura(Saga University Japan) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 2 14:40~15:00 Single Cell RNA Sequencing Reveals Tranional Programs Associated with Myeloma Progression  ÀÌÇý¿Á(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 2 15:00~15:20 ulti-Omics Analysis and Modeling of DNA Methylation in Cancer  ±è¼±(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 2 15:20~15:45 Clinical Application of Next-Generation Sequencing in Acute Myeloid Leukemia  ¾ÈÀç¼÷(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 2 15:45~16:10 Challenges in the Introduction of Next-Generation Sequencing for Diagnostics of Hematologic Malignancies  À̽ÂÅÂ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 2 16:25~16:55 Novel Strategies to Overcome Relapsed/Refractory Multiple Myeloma  Suzanne Trudel(University of Toronto Canada) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 2 16:55~17:25 MRD Negativity - The Foremost Important Goal of Myeloma Treatment?  Bruno Paiva(University of Navarra Spain) 
±³À°½Ã°£ 04¿ù 01ÀÏ Room 2 17:25~17:50 Primary Amyloidosis  ±è±âÇö(¼º±Õ°üÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) 2021 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2021)-4¿ù 1ÀÏ : 2021-04-01""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 1Çбâ À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ - ±¸°­ÀÛ¿­ÁõÈıº(Burning mouth syndrome) : 2021-04-01
´ÙÀ½±Û (¿Â¶óÀÎ) 2021 ´ëÇÑÅëÁõ¿¬±¸ÇÐȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ : 2021-03-28
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
219 ÀÎõ Á¦3ȸ ÀÎÇϴ뺴¿ø ¼Ò¾Æû¼Ò³â°ú ±³À°°­Á : 2018-09-08 0 847 2018-07-28
218 ¼­¿ï Á¦ 19ȸ ´ëÇÑÅõ¼®Çùȸ Ãß°è ½ÉÆ÷Áö¿ò : 2018-09-08 1 675 2018-07-28
217 ¼­¿ï ´ëÇѽÉÀåÇÐȸ EP Review Course 2018-2 : 2018-09-08 0 943 2018-07-28
216 ÀüºÏ 2018³â Á¦29ȸ ´ëÇÑ°£ÇÐȸ Ãß°è Single Topic Symposium ¹× ÃÊÀ½ÆÄ Hands-on : 2018-09-08 0 373 2018-07-28
215 ÀÎõ 2018³â ±¹Á¦¼º¸ðº´¿ø °³¿øÀÇ ¿¬¼ö°­Á : 2018-09-08 0 539 2018-07-28
214 ÀÎõ °¡ÃµÀÇ´ë±æº´¿ø È£½ºÇǽº ¿ÏÈ­ÀÇ·á Á¤Âø°ú È®´ë¸¦ À§ÇÑ ÀÎõÁö¿ª¾Ï¼¾ÅÍ ½ÉÆ÷Áö¿ò : 2018-09-08 0 1,211 2018-07-28
213 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª : 2018-09-07 0 304 2018-07-28
212 °æ±â ¸íÁöº´¿ø The 3nd MYONGJI INTERNATIONAL LIVER SYMPOSIUM : 2018-09-07 0 390 2018-07-28
211 ¼­¿ï 2018³âµµ ´ëÇѺñ¸¸ÇÐȸ ±¹Á¦Çмú´ëȸ(ICOMES 2018) - 09/07 : 2018-09-07 0 471 2018-07-28
210 ¼­¿ï 2018³â ¼­¿ï¾Æ»êº´¿ø ¾Ïº´¿ø ½ÉÆ÷Áö¾ö : 2018-09-07 0 487 2018-07-28
209 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ 2018³â ¹Î°£¡¤°ø°øÇù·Â(PPM) ±¹°¡°áÇÙ°ü¸®»ç¾÷ Æò°¡´ëȸ : 2018-09-07 0 553 2018-07-28
208 ´ë±¸ ±¹¸³ÀÇ·á¿ø °ø°øÀÇ·á Consensus conference(4Â÷: °æ»óÁ¦ÁÖ±Ç) : 2018-09-07 0 592 2018-07-28
207 ¼­¿ï 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ±³À°[»çÀüµî·Ï Çʼö] : 2018-09-07 0 281 2018-07-28
206 ¼­¿ï °í·Á´ëÇб³¾È¾Ïº´¿ø ÀÏÂ÷ ÀÇ·áÁø°ú ÇÔ²²ÇÏ´Â ½É¹æ¼¼µ¿ÀÇ Ä¡·á : 2018-09-07 0 525 2018-07-28
205 ¼­¿ï ´ëÇÑÀÇ»çÇùȸ [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] ÀÇ·á»ç°í¿Í Á¶Á¤ ÁßÀç / ¼³¸íÀǹ« : 2018-09-06 0 375 2018-07-28
1361 | 1362 | 1363 | 1364 | 1365 | 1366 | 1367 | 1368 | 1369 | 1370
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷